in patients with niddm , the antibody titer regardless of insulin treatment , was higher than in age-matched subjects with igt ( 18.5 +/- 13.1 u/ml in niddm patients receiving insulin , 14.8 +/- 8.1 u/ml in niddm patients not receiving insulin , and 8.8 +/- 3.9 u/ml in igt patients [ p less than .001 ] for either of niddm groups v igt ) .
C0011860
1
C0011849
niddm